Furosemide (Ascites / Cirrhosis)
Brand names: Lasix, Frusemide
Adult dose
Paediatric dose
Dose adjustments
Higher doses required in renal impairment (loop diuretics retain efficacy but dose must be increased). Avoid with aminoglycosides (additive nephrotoxicity and ototoxicity).
Use with caution — electrolyte disturbances may precipitate hepatic encephalopathy. Target maximum 0.5kg/day weight loss in cirrhosis without peripheral oedema.
BNF for Children: Oral: 0.5–2mg/kg BD–TDS (max 80mg per dose). IV: 0.5–1mg/kg (max 40mg) over 5 minutes — repeat every 6–8 hours if needed. Neonates: 0.5–1mg/kg every 12–24 hours. Source: BNF for Children 2024.
Clinical pearls
- Cirrhosis ratio rule: furosemide and spironolactone are always used in a 40:100mg ratio (furo:spiro). This maintains electrolyte neutrality. Furosemide alone causes severe hyponatraemia in cirrhosis.
- IV rate limit: furosemide IV must not exceed 4mg/minute — faster rates cause sensorineural hearing loss (permanent ototoxicity).
- Oral to IV conversion: furosemide oral bioavailability is ~50%. If converting from oral to IV, halve the dose (e.g., oral 80mg → IV 40mg).
- Antidote for overdose: IV fluid resuscitation with normal saline; correct electrolytes. No specific antidote.
Contraindications
- Anuria
- Severe hypokalaemia or hyponatraemia
- Dehydration
- Addison's disease
- Comatose states associated with liver cirrhosis (relative — use with extreme caution)
Side effects
- Hypokalaemia (most common — add potassium supplementation or combine with spironolactone)
- Hyponatraemia (especially in cirrhosis — restrict furosemide if Na⁺ <125mmol/L)
- Hypomagnesaemia
- Dehydration and pre-renal azotaemia
- Ototoxicity (at high IV doses or with rapid infusion — especially with concomitant aminoglycosides)
- Hyperglycaemia (mild)
- Gout (hyperuricaemia)
Interactions
- Aminoglycosides (gentamicin, amikacin): additive ototoxicity and nephrotoxicity — avoid combination where possible
- ACE inhibitors / ARBs: additive hypotension and acute kidney injury risk — monitor renal function
- NSAIDs: reduce diuretic efficacy and worsen renal function in cirrhosis
- Lithium: furosemide increases lithium levels — monitor lithium levels
- Digoxin: hypokalaemia from furosemide increases digoxin toxicity risk — monitor K⁺ and digoxin levels
Monitoring
- Serum electrolytes (Na⁺, K⁺, Mg²⁺) — minimum twice weekly in cirrhotic ascites
- Renal function (U&E, creatinine)
- Weight (daily in inpatients)
- Blood pressure
- Hearing (if high-dose IV prolonged use)
Reference: BNFc; BNF 90; EASL Cirrhosis Guidelines 2018; Baveno VII Consensus 2022; BNF for Children 2024. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
- Lower Gastrointestinal Bleed · BSG 2019; NICE NG141
- Variceal Upper GI Bleed · BSG 2015; Baveno VII (2022)
- Spontaneous Bacterial Peritonitis (SBP) · BSG / EASL 2018
- Hepatorenal Syndrome · EASL 2018; ICA 2015
- Hepatic Encephalopathy · EASL 2014; West Haven criteria
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021